|
|
||||||||
School of Pharmacy, University of Connecticut, Storrs, CT 06269
HLA-A*1101 is one of the most common human class I alleles worldwide. An increased frequency of HLA-A*1101 has been observed in cohorts of female sex workers from Northern Thailand who are highly exposed to HIV-1 and yet have remained persistently seronegative. In view of this apparent association of HLA-A*1101 with resistance to acquisition of HIV-1 infection, and given the importance of eliciting strong CTL responses to control and eliminate HIV-1, we have determined the crystal structure of HLA-A*1101 complexed with two immunodominant HIV-1 CTL epitopes: the nonamer reverse transcriptase(313321) (AIFQSSMTK) and decamer Nef(7382) (QVPLRPMTYK) peptides. The structures confirm the presence of primary anchor residues P2-Ile/-Val and P9-/P10-Lys, and also clearly reveal the presence of secondary anchor residues P6-Ser for reverse transcriptase and P7-Met for Nef. The overall backbone conformation of both peptides is defined as two bulges that are separated by a more buried middle residue. In this study, we discuss how this topology may offer functional advantages in the selection and presentation of HIV-1 CTL epitopes by HLA-A*1101. Overall, this structural analysis permits a more accurate definition of the peptide-binding motif of HLA-A*1101, the characterization of its antigenic surface, and the correlation of molecular determinants with resistance to HIV-1 infection. These studies are relevant for the rational design of HLA-A*1101-restricted CTL epitopes with improved binding and immunological properties for the development of HIV-1 vaccines.
This article has been cited by other articles:
![]() |
A. H. Bakker, R. Hoppes, C. Linnemann, M. Toebes, B. Rodenko, C. R. Berkers, S. R. Hadrup, W. J. E. van Esch, M. H. M. Heemskerk, H. Ovaa, et al. Conditional MHC class I ligands and peptide exchange technology for the human MHC gene products HLA-A1, -A3, -A11, and -B7 PNAS, March 11, 2008; 105(10): 3825 - 3830. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Liu, J. Fu, and M. Bouvier Allele- and Locus-Specific Recognition of Class I MHC Molecules by the Immunomodulatory E3-19K Protein from Adenovirus J. Immunol., April 1, 2007; 178(7): 4567 - 4575. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Chu, Z. Lou, Y. W. Chen, Y. Liu, B. Gao, L. Zong, A. H. Khan, J. I. Bell, Z. Rao, and G. F. Gao First Glimpse of the Peptide Presentation by Rhesus Macaque MHC Class I: Crystal Structures of Mamu-A*01 Complexed with Two Immunogenic SIV Epitopes and Insights into CTL Escape J. Immunol., January 15, 2007; 178(2): 944 - 952. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Racape, F. Connan, J. Hoebeke, J. Choppin, and J.-G. Guillet Influence of dominant HIV-1 epitopes on HLA-A3/peptide complex formation PNAS, November 28, 2006; 103(48): 18208 - 18213. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Lichterfeld, K. L. Williams, S. K. Mui, S. S. Shah, B. R. Mothe, A. Sette, A. Kim, M. N. Johnston, N. Burgett, N. Frahm, et al. T cell receptor cross-recognition of an HIV-1 CD8+ T cell epitope presented by closely related alleles from the HLA-A3 superfamily Int. Immunol., July 1, 2006; 18(7): 1179 - 1188. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Zhang, J. Fu, Q. Zhao, Y. He, L. Jin, H. Zhang, J. Yao, L. Zhang, and F.-S. Wang Differential Restoration of Myeloid and Plasmacytoid Dendritic Cells in HIV-1-Infected Children after Treatment with Highly Active Antiretroviral Therapy J. Immunol., May 1, 2006; 176(9): 5644 - 5651. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Mongkolsapaya, T. Duangchinda, W. Dejnirattisai, S. Vasanawathana, P. Avirutnan, A. Jairungsri, N. Khemnu, N. Tangthawornchaikul, P. Chotiyarnwong, K. Sae-Jang, et al. T Cell Responses in Dengue Hemorrhagic Fever: Are Cross-Reactive T Cells Suboptimal? J. Immunol., March 15, 2006; 176(6): 3821 - 3829. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Liu, W. F. Stafford, and M. Bouvier The Endoplasmic Reticulum Lumenal Domain of the Adenovirus Type 2 E3-19K Protein Binds to Peptide-Filled and Peptide-Deficient HLA-A*1101 Molecules J. Virol., November 1, 2005; 79(21): 13317 - 13325. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. M. Allen, X. G. Yu, E. T. Kalife, L. L. Reyor, M. Lichterfeld, M. John, M. Cheng, R. L. Allgaier, S. Mui, N. Frahm, et al. De Novo Generation of Escape Variant-Specific CD8+ T-Cell Responses following Cytotoxic T-Lymphocyte Escape in Chronic Human Immunodeficiency Virus Type 1 Infection J. Virol., October 15, 2005; 79(20): 12952 - 12960. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. B. E. Stewart-Jones, G. Gillespie, I. M. Overton, R. Kaul, P. Roche, A. J. McMichael, S. Rowland-Jones, and E. Y. Jones Structures of Three HIV-1 HLA-B*5703-Peptide Complexes and Identification of Related HLAs Potentially Associated with Long-Term Nonprogression J. Immunol., August 15, 2005; 175(4): 2459 - 2468. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |